B. Pharmacy

UNIT 2 – Quantitative Structure Activity Relationship (QSAR) Notes

In modern medicinal chemistry, intuition and trial-and-error approaches are no longer sufficient to design effective and safe drugs. The need to predict biological activity before synthesis has led to the development of Quantitative Structure–Activity Relationship (QSAR) methods. QSAR provides a scientific bridge between chemical structure and biological activity, enabling rational drug design, optimization of lead […]

B. Pharmacy

UNIT 1 – Introduction to Drug Discovery and Development Notes

Drug discovery and development is a complex, multidisciplinary journey that transforms scientific ideas into safe and effective medicines. In today’s competitive and highly regulated pharmaceutical landscape, understanding the stages of drug discovery, lead identification strategies, and rational drug design approaches such as analog-based drug design is essential for pharmacy and life science students. This article

B. Pharmacy

UNIT 5 – Regulatory Requirements and Pharmacovigilance of Herbal Medicines Notes

Herbal medicines are used by millions of people worldwide as part of traditional, complementary, and integrative healthcare systems. As their use expands beyond local traditions into regulated national and international markets, robust regulatory requirements and safety monitoring mechanisms have become essential. Modern regulation of herbal medicines now combines pharmacopoeial standards, pharmacovigilance systems, and scientific standardization

B. Pharmacy

UNIT 4 – Stability Testing, Standardization, and Regulatory Compliance in Herbal Medicines Notes

As herbal medicines gain wider acceptance in regulated global markets, scientific validation and regulatory compliance have become as important as traditional knowledge. Stability testing, chromatographic standardization, regulatory documentation, and adherence to legal frameworks such as GMP and the Drugs & Cosmetics Act together ensure that herbal products are safe, effective, and of consistent quality. These

B. Pharmacy

UNIT 3 – EU and ICH Guidelines for Quality Control of Herbal Drugs Notes

Herbal medicines occupy a unique position in global healthcare, combining traditional knowledge with modern therapeutic use. As their popularity grows across regulated markets, particularly in Europe, the need for robust quality control and scientific validation has become increasingly important. To address this, international frameworks developed by the European Union (EU), the International Council for Harmonisation

B. Pharmacy

UNIT 2 –Quality Assurance in the Herbal Drug Industry Notes

The global demand for herbal medicines and traditional systems of healthcare has increased rapidly in recent decades. With this growth comes a heightened responsibility to ensure that herbal drugs are safe, effective, and of consistent quality. Quality assurance in the herbal drug industry integrates scientific principles with traditional knowledge, supported by international standards such as

B. Pharmacy

UNIT 1 – Basic Tests for Drugs — Ensuring Quality, Safety, and Authenticity in Medicines Notes

Quality control is the foundation of safe and effective healthcare. Before any drug—whether synthetic, herbal, or finished dosage form—reaches patients, it must undergo rigorous testing to confirm its identity, purity, strength, and safety. Basic tests for drugs play a critical role in preventing substandard, adulterated, or counterfeit products from entering the supply chain. With the

B. Pharmacy

UNIT 5 – Pharmacogenomics, Special Populations, and Regulatory Frameworks Notes

As pharmacovigilance evolves, the focus is shifting from a “one-size-fits-all” approach to more personalized and population-specific safety monitoring. Pharmacogenomics, evaluation of drug safety in special populations, and harmonized regulatory frameworks now play a crucial role in understanding and preventing adverse drug reactions (ADRs). At the same time, global and national bodies such as CIOMS and

B. Pharmacy

UNIT 4 –Safety Data Generation and ICH Guidelines Notes

Safety data generation is the backbone of pharmacovigilance, ensuring that medicines remain safe from early discovery through real-world use. Modern drug regulation relies on a continuous flow of safety information generated during preclinical testing, clinical trials, and post-approval monitoring. These activities are globally harmonized through International Council for Harmonisation (ICH) guidelines, which provide a common

B. Pharmacy

UNIT 3 – Vaccine Safety Surveillance and Pharmacovigilance Notes

Vaccines are among the most effective public health interventions, preventing millions of deaths each year. However, because vaccines are administered to large and often healthy populations, their safety is subject to intense scrutiny. Vaccine safety surveillance and pharmacovigilance systems are designed to detect, assess, and communicate risks in a transparent manner, thereby maintaining public confidence

Scroll to Top